MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.
Lin CH, Tsai CH, Yeh CT, Liang JL, Hung WC, Lin FC, Chang WL, Li HY, Yao YC, Hsu TI, Lee YC, Wang YC, Sheu BS, Lai WW, Calkins MJ, Hsiao M, Lu PJ.
Lin CH, et al. Among authors: wang yc.
Oncotarget. 2016 Jun 28;7(26):39680-39693. doi: 10.18632/oncotarget.9444.
Oncotarget. 2016.
PMID: 27203740
Free PMC article.